Chelating the valley of death: Deferoxamine’s path from bench to wound clinic

There is undisputable benefit in translating basic science research concretely into clinical practice, and yet, the vast majority of therapies and treatments fail to achieve approval. The rift between basic research and approved treatment continues to grow, and in cases where a drug is granted appro...

Full description

Bibliographic Details
Main Authors: Jennifer B. Parker, Michelle F. Griffin, Mauricio A. Downer, Deena Akras, Charlotte E. Berry, Asha C. Cotterell, Geoffrey C. Gurtner, Michael T. Longaker, Derrick C. Wan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1015711/full